Literature DB >> 20559534

Pathological complete remission of advanced hepatocellular carcinoma with main portal vein tumor thrombosis by hepatic arterial infusion chemotherapy.

Yong Gil Kim1, Jong Ryul Eun, Tae Nyeun Kim, Heon Ju Lee, Jae Woon Kim, Jay Chun Chang, Sung Su Yun, Joon Hyuk Choi.   

Abstract

Cures for advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) are rare and difficult. We report a case of pathologically confirmed complete remission of HCC induced by hepatic arterial infusion chemotherapy (HAIC). A 45-year-old male patient had a massive HCC in the right lobe of the liver and tumor thrombus in the right and main portal veins. He achieved a partial response after two cycles of HAIC with 5-fluorouracil (750 mg/m(2)) and cisplatin (25 mg/m(2)). After the completion of six cycles he received a curative partial hepatectomy, and histopathology revealed complete necrosis without any viable tumor cell. He was in good health at a 4-month follow-up. These results suggest that this regimen is a promising therapeutic modality for the treatment of advanced HCC with PVTT.

Entities:  

Keywords:  5-fluorouracil; Chemotherapy; Complete remission; Hepatocellular carcinoma; Portal vein tumor thrombosis

Year:  2010        PMID: 20559534      PMCID: PMC2886937          DOI: 10.5009/gnl.2010.4.2.266

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  17 in total

1.  Contrast enhanced ultrasound in assessing therapeutic response in ablative treatments of hepatocellular carcinoma.

Authors:  Zeno Sparchez; Pompilia Radu; Ofelia Anton; Mihai Socaciu; Radu Badea
Journal:  J Gastrointestin Liver Dis       Date:  2009-06       Impact factor: 2.008

2.  Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues.

Authors:  S Okada
Journal:  Hepatology       Date:  1998-06       Impact factor: 17.425

Review 3.  Systemic therapy for hepatocellular carcinoma.

Authors:  T W Leung; P J Johnson
Journal:  Semin Oncol       Date:  2001-10       Impact factor: 4.929

4.  Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.

Authors:  Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sato; Ryosuke Tateishi; Takuma Teratani; Shuichiro Shiina; Masao Omata
Journal:  Cancer       Date:  2006-05-01       Impact factor: 6.860

5.  Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jong Ryul Eun; Heon Ju Lee; Hee Jung Moon; Tae Nyeun Kim; Jae Woon Kim; Jay Chun Chang
Journal:  Scand J Gastroenterol       Date:  2009       Impact factor: 2.423

6.  Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.

Authors:  Eiji Ando; Masatoshi Tanaka; Fumihiko Yamashita; Ryoko Kuromatsu; Shigeru Yutani; Kazuta Fukumori; Shuji Sumie; Yoichi Yano; Koji Okuda; Michio Sata
Journal:  Cancer       Date:  2002-08-01       Impact factor: 6.860

7.  Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: Is the addition of subcutaneous interferon-alpha-2b beneficial?

Authors:  Satoe Takaki-Hamabe; Takahiro Yamasaki; Issei Saeki; Yohei Harima; Kohsuke Okita; Shuji Terai; Isao Sakaida
Journal:  Hepatol Res       Date:  2008-11-05       Impact factor: 4.288

8.  Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

Authors:  Ann-Lii Cheng; Yoon-Koo Kang; Zhendong Chen; Chao-Jung Tsao; Shukui Qin; Jun Suk Kim; Rongcheng Luo; Jifeng Feng; Shenglong Ye; Tsai-Sheng Yang; Jianming Xu; Yan Sun; Houjie Liang; Jiwei Liu; Jiejun Wang; Won Young Tak; Hongming Pan; Karin Burock; Jessie Zou; Dimitris Voliotis; Zhongzhen Guan
Journal:  Lancet Oncol       Date:  2008-12-16       Impact factor: 41.316

9.  Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.

Authors:  Ahsun Riaz; Robert K Ryu; Laura M Kulik; Mary F Mulcahy; Robert J Lewandowski; Jeet Minocha; Saad M Ibrahim; Kent T Sato; Talia Baker; Frank H Miller; Steven Newman; Reed Omary; Michael Abecassis; Al B Benson; Riad Salem
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544

10.  The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma.

Authors:  H Toyoda; S Nakano; T Kumada; I Takeda; K Sugiyama; T Osada; S Kiriyama; T Suga; M Takahashi
Journal:  Oncology       Date:  1995 Jul-Aug       Impact factor: 2.935

View more
  5 in total

1.  Current chemotherapies for advanced hepatocellular carcinoma.

Authors:  Kazuhiro Nouso
Journal:  Clin J Gastroenterol       Date:  2013-02-06

2.  Complete response for advanced liver cancer during sorafenib therapy: case report.

Authors:  Rodolfo Sacco; Irene Bargellini; Giannelli Gianluigi; Marco Bertini; Elena Bozzi; Emanuele Altomare; Valentina Battaglia; Antonio Romano; Michele Bertoni; Alfonso Capria; Giampaolo Bresci; Carlo Bartolozzi
Journal:  BMC Gastroenterol       Date:  2011-01-17       Impact factor: 3.067

3.  Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report.

Authors:  Keisuke Arai; Takumi Fukumoto; Motofumi Tanaka; Kaori Kuramitsu; Masahiro Kido; Hisoka Kinoshita; Taku Matsumoto; Hirochika Toyama; Sadaki Asari; Tadahiro Goto; Tetsuo Ajiki; Yonson Ku
Journal:  Surg Case Rep       Date:  2016-05-26

4.  Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation.

Authors:  Yuki Koga; Toru Beppu; Katsunori Imai; Kunitaka Kuramoto; Tatsunori Miyata; Yuki Kitano; Shigeki Nakagawa; Hirohisa Okabe; Kazutoshi Okabe; Yo-Ichi Yamashita; Akira Chikamoto; Hideo Baba
Journal:  Surg Case Rep       Date:  2018-08-29

5.  Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.

Authors:  Shusei Sano; Shinji Nakata; Shuichi Wada; Masatsugu Kuroiwa; Hiroki Sakai; Kei Kusama; Taiichi Machida; Akihito Nishio; Ichiro Ito; Harutsugu Sodeyama
Journal:  World J Surg Oncol       Date:  2019-12-26       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.